Okas M - Search Results

1

Rapid salvage treatment with virus-specific T cells for therapy-resistant disease.

Uhlin M, Gertow J, Uzunel M, Okas M, Berglund S, Watz E, Brune M, Ljungman P, Maeurer M, Mattsson J. Uhlin M, et al. Among authors: okas m. Clin Infect Dis. 2012 Oct;55(8):1064-73. doi: 10.1093/cid/cis625. Epub 2012 Jul 17. Clin Infect Dis. 2012. PMID: 22806594 Clinical Trial.

2

Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors: a single centre study.

Remberger M, Mattsson J, Hassan Z, Karlsson N, LeBlanc K, Omazic B, Okas M, Sairafi D, Ringdén O. Remberger M, et al. Among authors: okas m. Bone Marrow Transplant. 2008 Feb;41(4):399-405. doi: 10.1038/sj.bmt.1705913. Epub 2007 Nov 5. Bone Marrow Transplant. 2008. PMID: 17982493

3

Ringdén O, Okas M, Uhlin M, Uzunel M, Remberger M, Mattsson J. Ringdén O, et al. Among authors: okas m. Bone Marrow Transplant. 2008 Nov;42(10):643-8. doi: 10.1038/bmt.2008.239. Epub 2008 Sep 1. Bone Marrow Transplant. 2008. PMID: 18762760 Clinical Trial.

4

Increased frequency and responsiveness of PSA-specific T cells after allogeneic hematopoetic stem-cell transplantation.

Uhlin M, Okas M, Karlsson H, Gertow J, Henningsohn L, Ringdén O, Kärre K, Levitsky V, Mattsson J. Uhlin M, et al. Among authors: okas m. Transplantation. 2009 Feb 27;87(4):467-72. doi: 10.1097/TP.0b013e3181949c16. Transplantation. 2009. PMID: 19307781

5

Stable mixed donor-donor chimerism after double cord blood transplantation.

Berglund S, Okas M, Gertow J, Uhlin M, Mattsson J. Berglund S, et al. Among authors: okas m. Int J Hematol. 2009 Nov;90(4):526-531. doi: 10.1007/s12185-009-0398-y. Epub 2009 Aug 22. Int J Hematol. 2009. PMID: 19697099 Free article.

6

A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation.

Uhlin M, Okas M, Gertow J, Uzunel M, Brismar TB, Mattsson J. Uhlin M, et al. Among authors: okas m. Cancer Immunol Immunother. 2010 Mar;59(3):473-7. doi: 10.1007/s00262-009-0789-1. Epub 2009 Nov 12. Cancer Immunol Immunother. 2010. PMID: 19908041

7

Clinical expansion of cord blood-derived T cells for use as donor lymphocyte infusion after cord blood transplantation.

Okas M, Gertow J, Uzunel M, Karlsson H, Westgren M, Kärre K, Ringden O, Mattsson J, Uhlin M. Okas M, et al. J Immunother. 2010 Jan;33(1):96-105. doi: 10.1097/CJI.0b013e3181b291a4. J Immunother. 2010. PMID: 19952951

8

Characterization of long-term mixed donor-donor chimerism after double cord blood transplantation.

Gertow J, Berglund S, Okas M, Uzunel M, Berg L, Kärre K, Mattsson J, Uhlin M. Gertow J, et al. Among authors: okas m. Clin Exp Immunol. 2010 Oct;162(1):146-55. doi: 10.1111/j.1365-2249.2010.04212.x. Epub 2010 Aug 20. Clin Exp Immunol. 2010. PMID: 20731674 Free PMC article.

9

Expansion of T-cells from the cord blood graft as a predictive tool for complications and outcome of cord blood transplantation.

Gertow J, Berglund S, Okas M, Kärre K, Remberger M, Mattsson J, Uhlin M. Gertow J, et al. Among authors: okas m. Clin Immunol. 2012 May;143(2):134-44. doi: 10.1016/j.clim.2012.01.018. Epub 2012 Feb 10. Clin Immunol. 2012. PMID: 22386776 Free article.

10

Causes of death after first time venous thromboembolism.

Lonnberg F, Roos A, Farm M, Heurlin A, Okas M, Gigante B, Siddiqui AJ. Lonnberg F, et al. Among authors: okas m. Thromb J. 2024 Feb 1;22(1):16. doi: 10.1186/s12959-024-00586-8. Thromb J. 2024. PMID: 38303070 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page